GENENTA SCIENCE(SP.ADR)/1 (K5F) — Net Asset Quality Index
GENENTA SCIENCE(SP.ADR)/1 (K5F) has a Net Asset Quality Index of 68.5% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €31.89 Million minus total liabilities of €10.05 Million yields net assets of €21.84 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of GENENTA SCIENCE(SP.ADR)/1 to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
GENENTA SCIENCE(SP.ADR)/1 Net Asset Quality Index Over Time (2021–2025)
This chart shows how GENENTA SCIENCE(SP.ADR)/1's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 68.5%, representing net assets of €21.84 Million against total assets of €31.89 Million EUR. See GENENTA SCIENCE(SP.ADR)/1 working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for GENENTA SCIENCE(SP.ADR)/1 (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for GENENTA SCIENCE(SP.ADR)/1 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of GENENTA SCIENCE(SP.ADR)/1.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 68.5% | €21.84 Million | €31.89 Million | €10.05 Million | ▼ -15.8 pp |
| 2024 | 84.3% | €12.50 Million | €14.82 Million | €2.33 Million | ▼ -7.1 pp |
| 2023 | 91.4% | €20.43 Million | €22.35 Million | €1.91 Million | ▼ -1.7 pp |
| 2022 | 93.1% | €31.14 Million | €33.44 Million | €2.30 Million | ▼ -4.0 pp |
| 2021 | 97.1% | €38.86 Million | €40.03 Million | €1.17 Million | — |